| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | At MLS Bio we are addressing the world's most critical health challenges through patented, novel small-molecule therapies with our breakthrough compounds targeting a new cellular mode of action, offering novel approaches to treatment in the most impactful global markets. Our Global team of experienced medical researchers, commercialization and technical experts are committed to developing treatments that are more effective, accessible, and better tolerated, delivering novel solutions and improving the lives of patients facing cancer and other life-threatening diseases worldwide. Our Strategic Focus is Oncology, where we are advancing a robust pipeline targeting unmet needs in solid tumor cancers. We aim to develop solutions in other high-impact global markets, bringing transformative therapies to market, delivering better outcomes for patients facing cancer and other life-threatening diseases, improving lives worldwide. |
| Category: | Hardware & devices, Health & biotech |
| URL: | http://www.mlsbio.com |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2017 |
| Address: | Studley Rd, Heidelberg, Victoria 3084, AU |
| State: | Victoria |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://linkedin.com/company/mls-bio |
| Founders: | |
| Awards won: | |
